PFSA
Profusa, Inc. Common Stock · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-04-15
Figures on this page computed 2026-11-08 12:40 UTC
Last close
0.62USD
Market data, 2026-11-04
Except where said otherwise: 10-K for 2025, filed 2026-04-15
n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- computed
- 10-K for 2025, filed 2026-04-15
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
- 10-Q for 2025, filed 2026-08-19
- 10-K for 2025, filed 2026-04-15
- 10-Q for 2025, filed 2026-05-15
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-K for 2025, filed 2026-04-15
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
- 10-K for 2025, filed 2026-04-15
- 10-Q for 2025, filed 2026-08-19
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-07
- Reported in
- USD
- computed
Safety is the furthest below its sector's middle: 0.02 against 0.72 on the market's range.
- Growth-288.1%8 of 100, below its sector
- Returns on capital-949.0%0 of 100, below its sector
- Marginsn/anot placed
- Pricen/anot placed
- Safety0.172 of 100, below its sector
- What it pays outn/anot placed
- Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
- Price: n/aWe do not hold this figure for this company, so there is nothing to place.
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
All from 100
lens 2 of 9Shares in issue
483- Sales, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.
- Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.
Shares in issue is at 483, against 100 in 2021.
Shares in issue is at 483, against 100 in 2021.
Every figure in this lens
Except where said otherwise: 10-K for 2025, filed 2026-04-15
Sales, where the first year is 100n/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
Profit, where the first year is 100n/a
Not held.
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD
Shares in issue, where the first year is 100483
- Source
- filed
- Statement
- income
- Fiscal year
- 2025
- Accession
- 0001213900-26-044046
- Reported in
- USD